Target intelligence / Profile preview

Thyroid hormone receptor beta (THRB)

Target
THRB
Molecular classification
Nuclear hormone receptor, Receptor, Transcription factor
01

Overview

Thyroid hormone receptor beta is a nuclear hormone receptor encoded by the THRB gene located on chromosome 3. It functions primarily as a ligand-dependent transcription factor that mediates cellular responses to triiodothyronine (T3) and thyroxine (T4), regulating genes involved in development, differentiation, metabolism—especially hepatic lipid and carbohydrate pathways—and feedback control of TSH secretion from the pituitary gland. The predominant isoforms are expressed mainly in liver, kidney, pituitary gland, and brain. Mutations can cause resistance to thyroid hormones with clinical manifestations ranging from goiter without typical hyperthyroidism symptoms to metabolic disturbances. Loss or downregulation has been implicated in certain cancers where it may function as a tumor suppressor gene[1][2][6][8].

Other names
TRβNR1A2ERBA2THR1TRB
02

Mechanism of action

Drugs targeting this molecule typically act as agonists that selectively bind to and activate the beta isoform of the thyroid hormone receptor. This leads to modulation of gene expression involved in cholesterol and triglyceride metabolism with reduced cardiac side effects compared to non-selective agonists[3][7].

03

Biological functions

Regulation of gene transcription in response to thyroid hormones (triiodothyronine/T3 and thyroxine/T4)Control of hepatic carbohydrate and lipid metabolismFeedback regulation of thyrotropin-stimulating hormone (TSH) in the pituitary gland[6][9]Modulation of metabolic rate and energy expenditure[3][6]
04

Disease associations

Cancer (notably papillary thyroid carcinoma, where it acts as a tumor suppressor)[8]Metabolic disorders (including dyslipidemia, obesity, nonalcoholic fatty liver disease)[3][7]Resistance to thyroid hormone syndrome (Refetoff syndrome)[5]
05

Safety considerations

Notable safety concerns include unwanted systemic effects such as suppression of the hypothalamic-pituitary-thyroid axis, cardiac side effects, muscle metabolism disturbances, and bone turnover issues when using non-selective or high-dose agonists. Selectivity for TRβ over other isoforms is pursued to minimize these risks[3][7].
06

Interacting drugs

Sobetirome (GC‑1)

1 more in the full profile.

07

Biomarkers

Mutations or altered expression levels in THRB can serve as biomarkers for resistance to thyroid hormone syndromes or certain cancers such as papillary thyroid carcinoma. Downregulation by specific microRNAs is also observed in tumors[5][8].

Beyond the preview

Go deeper on Thyroid hormone receptor beta (THRB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thyroid hormone receptor beta (THRB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call